HELUS PHARMA INC
HELP · NASDAQ
Updated at 2026-10-13 15:23:11
- Today's High
- $11.33
- Today’s Low
- $10.04
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $11.78
- Previous Close
- $11.03
- Volume
- 2.33M
- Market Cap
- $1.91M
- P/E Ratio
- --
- EPS
- $-4.25
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 100 KING STREET WEST, TORONTO, ON, CANADA, M5X 1C9
- Country
- CA
- Listing Date
- 2018-01-05
- Fiscal Year End
- March
- Shares Outstanding
- 69.87M
- CIK
- 0001833141
- Website
- www.helus.com
Cybin Inc., doing business as Helus Pharma, a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. The company is headquartered in Toronto, Canada.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$1.29M
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$47.8M
2026-03-31
$47.85M
2025-12-31
$41.17M
2025-09-30
$40.29M
Net Income
2026-06-30
-$46.6M
2026-03-31
-$46.99M
2025-12-31
-$42.63M
2025-09-30
-$47.03M
Net Profit Margin
2026-06-30
--
2026-03-31
-3.61K%
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.91
2026-03-31
$-1.02
2025-12-31
$-1.36
2025-09-30
$-1.65
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$47.8M
2026-03-31
-$47.82M
2025-12-31
-$41.15M
2025-09-30
-$40.25M
Effective Tax Rate
2026-06-30
--
2026-03-31
-33.38%
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $1.29M | $0 | $0 |
| Operating Expenses | $47.8M | $47.85M | $41.17M | $40.29M |
| Net Income | -$46.6M | -$46.99M | -$42.63M | -$47.03M |
| Net Profit Margin | -- | -3.61K% | -- | -- |
| Earnings Per Share | $-0.91 | $-1.02 | $-1.36 | $-1.65 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$47.8M | -$47.82M | -$41.15M | -$40.25M |
| Effective Tax Rate | -- | -33.38% | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.